Numbers Needed To Treat

Number of patients who need to be treated in order to prevent one additional bad outcome. It is the inverse of Absolute Risk Reduction.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
BACKGROUND Lifelong antiplatelet treatment is recommended after ischaemic vascular events, on the basis of trials done mainly in… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
Review
2014
Review
2014
Randomized controlled trials have demonstrated the efficacy of bisphosphonates (BP) in improving BMD and reducing fracture risk… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2012
2012
To compare the clinical efficiency of different modes of treatment of infertile couples and to estimate the possible benefit of… (More)
Is this relevant?
2009
2009
BACKGROUND Reporting numbers needed to treat (NNT) improves interpretability of trial results. It is unusual that continuous… (More)
Is this relevant?
Highly Cited
2009
Highly Cited
2009
CONTEXT Despite lacking evidence for its safety and efficacy, antipsychotic cotreatment is common in schizophrenia. OBJECTIVE… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 2
Is this relevant?
Review
2007
Highly Cited
2005
Highly Cited
2005
PURPOSE 5-Hydroxytryptamine-3 receptor antagonists (5-HT(3) antagonists) are effective for preventing acute chemotherapy-induced… (More)
Is this relevant?
Highly Cited
2003
Highly Cited
2003
Peripheral neuropathic pain syndromes (PNPS) are difficult to treat because commonly used analgesics are often ineffective when… (More)
Is this relevant?
Review
2000
Review
2000
Tricyclic antidepressants and anticonvulsants have become the mainstay in the treatment of pain in polyneuropathy. Within the… (More)
Is this relevant?
Review
1999
Review
1999
Tricyclic antidepressants and carbamazepine have become the mainstay in the treatment of neuropathic pain. Within the last decade… (More)
Is this relevant?